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We analyzed prospective data on 17,228 European 
patients who sought treatment at GeoSentinel sites from 
1997 to 2007. Gastrointestinal illness (particularly in tour-
ists), fever (those visiting friends and relatives [VFRs]), and 
skin disorders (in tourists) were the most common reasons 
for seeking medical care. Diagnoses varied by country of 
origin, region visited, or categories of travelers. VFRs who 
returned from sub-Saharan Africa and Indian Ocean islands 
were more likely to experience falciparum malaria than any 
other group. Multiple correspondence analysis identiﬁ  ed 
Italian, French, and Swiss VFRs and expatriate travelers 
to sub-Saharan Africa and Indian Ocean Islands as most 
likely to exhibit febrile illnesses. German tourists to South-
east and south-central Asia were most likely to seek treat-
ment for acute diarrhea. Non-European travelers (12,663 
patients from other industrialized countries) were less likely 
to acquire certain travel-associated infectious diseases. 
These results should be considered in the practice of travel 
medicine and development of health recommendations for 
European travelers.
I
n recent years, growth in international travel has been 
≈6% per year, and similar trends are expected in the fu-
ture (1). This growth has been strongly driven by travel-
ers to newly popular destinations in Asia and the Paciﬁ  c, 
Africa, and the Middle East (1). Approximately 80 million 
persons from industrialized nations travel to the developing 
world each year, and an estimated >200 million persons 
now reside outside their country of birth (1).
European travelers represent most of the international 
travelers, with Germany, United Kingdom, France, and 
Italy the leading countries of origin (2). With few excep-
tions, no European consensus exists on recommendations 
for travelers about risk assessment, malaria prophylaxis, 
or vaccinations. International references include the World 
Health Organization green book (3), which emphasizes 
risk assessment by rates of diseases in local populations; 
and the Centers for Disease Control and Prevention yellow 
book (4), which examines risk in the context of American 
travelers. Yet, whether these guidelines are appropriate in 
the European context is not known.
The intense international trafﬁ  c between Europe and 
the rest of the world means that travelers have become a 
key element in the global spread of infectious diseases. 
These diseases may be introduced into domestic European 
populations and environments that are receptive to further 
spread. In 2003, severe acute respiratory syndrome (SARS) 
was introduced to France by 1 patient who returned from 
Vietnam (5). Malaria has recently reemerged in Italy and 
in France (Corsica), resulting from local transmission by 
anopheline mosquitoes that fed on travelers who had be-
come infected with Plasmodium vivax during travel (6). 
More recently, chikungunya virus (CHIKV) appeared as 
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a paradigm of an infectious disease that rapidly became 
global as highly viremic travelers acted as efﬁ  cient car-
riers of the virus (7). After CHIKV-infected persons in 
eastern Africa, Indian Ocean islands, India, and Southeast 
Asia, a new CHIKV variant reached Europe and affected 
local populations in Italy through 1 infected traveler (the 
index case-patient) and transmission by indigenous Euro-
pean mosquito vectors (8). In April 2009, an inﬂ  uenza A 
pandemic (H1N1) 2009 virus emerged in humans in North 
America and reached Europe soon after through returned 
travelers (9).
European physicians should be prepared to encoun-
ter and recognize infectious imported diseases. Facing 
the symptoms and syndromes in the ill returned traveler 
requires an understanding of the common etiologic agents 
encountered by different populations of travelers (10). Ac-
curate epidemiologic data are needed about travel-associ-
ated infectious diseases in travelers returning to European 
countries. Some data on diseases among Europeans who 
traveled to developing countries recently have been pub-
lished but were limited to 1 country of origin (11–13), a 
short period of study, speciﬁ  c diseases (14–16), a speciﬁ  c 
destination (17), or a certain type of traveler (18). A com-
prehensive multicenter comparison of the spectrum of ill-
nesses among European travelers, including a broad sam-
ple of destinations, has been missing. Our objective in this 
study was to determine the epidemiology of travel-related 
infectious diseases in a large set of ill returned European 
travelers over a substantial period and to compare this with 
the epidemiology of disease in travelers from other indus-
trialized countries outside Europe.
Patients and Methods
Data Source
The GeoSentinel Surveillance Network consists of 
specialized travel/tropical medicine clinics on 6 continents 
where ill travelers are seen during or after traveling to a 
wide range of countries and where information about travel-
ers is prospectively recorded (19) in a standardized format. 
To be eligible for inclusion in the GeoSentinel database, 
patients must have crossed an international border and have 
received medical attention at a GeoSentinel clinic for a pre-
sumed travel-related illness. We included western Europe-
an patients who sought treatment at GeoSentinel sites after 
travel from March 1997 through November 2007. Persons 
were placed in 3 different categories: classic traveler, im-
migrant traveler, and expatriate traveler (Table 1). Reasons 
for travel were classiﬁ  ed as the following: tourism, busi-
ness, research/education, missionary/volunteer work, or 
visiting friends and relatives (VFRs). Individual countries 
visited were grouped into 12 regions (19). Medical data 
included the ﬁ  nal physician-assigned diagnosis, according 
to a standardized list of 556 possible individual diagnoses 
of infectious diseases that were also categorized under 21 
broad syndromes as previously described (19). European 
patients were compared with all other ill non-European re-
turned patients on the basis of information obtained from 
GeoSentinel sites in the United States, Canada, Australia, 
and New Zealand.
Statistical Analysis
Data were entered and managed in Microsoft Access 
(Microsoft Corp., Redmond, WA, USA). In our evaluation, 
proportionate morbidity refers to the number of cases of a 
speciﬁ  c diagnosis (or of a group of speciﬁ  c diagnosis within 
a syndrome group) compared with all cases of ill returned 
travelers seen at GeoSentinel clinics during the same peri-
od. Differences in proportions (qualitative variables) were 
tested by using Pearson χ2 or Fisher exact tests. Analysis of 
variance or Kruskal-Wallis tests were used for quantitative 
variables. Because of the large numbers of statistical tests 
performed, a p value <0.001 was considered signiﬁ  cant.
Diagnosis, exposure regions, residence region, and 
travel types were analyzed by using multiple correspon-
dence analysis (MCA) (20–22). MCA was performed by 
using the ANADEV freeware (www.lertim.org), developed 
by the Laboratory of Biomathematics, Faculty of Medi-
cine of Marseille. Odds ratios (ORs) (European vs. non-
European) by diagnosis were estimated by using logistic 
regression and adjusted for travel duration. All statistical 
tests were 2-sided. Percentages and odds ratios (with 95% 
conﬁ  dence intervals), comparisons, and graphic analysis 
were carried out by using the R 2.8.1 environment (www.r-
project.org).
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Table 1. Categories of ill European* returned travelers seen at 
GeoSentinel sites, 1997–2007 
Category Definition
Classic traveler  European country–born person living in 
Europe who traveled to a developing 
country and has returned to his or her home 
country. 
Immigrant traveler  Person born in a developing country who at 
some time has emigrated to Europe,† 
including refugees, where a permanent 
residence has been established, and who 
later travels to a developing country and 
returns to Europe. 
Expatriate traveler  European-born person who grew up in 
Europe and whose current country of 
residence is a developing country. They 
were included when they sought treatment 
at a GeoSentinel site after they returned to 
Europe and/or after travel while still 
expatriating. 
*From Western Europe (19). 
†Patients whose purpose of travel was the initial immigration travel from 
their birth country to Europe were excluded. Travel-related Infectious Diseases in Europe
Results
Demographic and Travel Data
A total of 17,228 European patients were included: 
13,913 (80.8%) classic travelers, 2,415 (14.0%) immigrant 
travelers, and 900 (5.2%) expatriate travelers (Figure 1). 
Demographic and travel data are presented in Table 2. 
Most patients were seen as outpatients who sought treat-
ment at the clinics <2 weeks post travel. Immigrant travel-
ers sought markedly less pretravel advice and were more 
likely to be inpatients than other groups; differences were 
signiﬁ   cant (p<0.0001). Furthermore, European patients’ 
main destination was Africa, followed by Asia; the propor-
tion of patients returning from sub-Saharan Africa, Indian 
Ocean islands, and south-central Asia was higher in sites 
in Italy, France, and the United Kingdom, respectively 
(Figure 2). Non-Europeans (12,663 patients) had a lower 
proportion of immigrant travelers in the inpatient category, 
and non-European expatriates were younger, had a longer 
duration of travel, and sought pretravel advice more often 
(p<0.0001).
Final Etiologic Diagnosis 
The proportionate morbidity of some broad syndromes 
or etiologic diagnoses was higher in patients travelling to 
speciﬁ  c regions. This was obvious for acute diarrhea in 
North Africa, south-central Asia, and the Middle East, and 
etiologic diagnosis such as Campylobacter spp. in south-
central and Southeast Asia, Shigella spp. in North Africa 
and south-central Asia, Giardia spp. in south-central Asia 
and South America and amebas in south-central Asia. Fe-
brile systemic illnesses were more frequently reported from 
Indian Ocean islands, sub-Saharan Africa, and Oceania. P. 
falciparum malaria was more frequently observed in travel-
ers returning from Indian Ocean islands and sub-Saharan 
Africa, P. vivax malaria in travelers from Oceania, Indian 
Ocean islands, and South America, and P. ovale and P. 
malariae malaria in travellers from Indian Ocean islands 
and sub-Saharan Africa. Dengue was more frequently re-
ported from Southeast Asia, chikungunya from Indian 
Ocean Islands, and rickettsioses from sub-Saharan Africa, 
and salmonellosis from south-central Asia. Proportionate 
morbidity for dermatologic conditions was higher in Oce-
ania, Southeast Asia, Central America, South America, and 
the Caribbean, including animal-related injuries requiring 
rabies postexposure prophylaxis (PEP) in North Africa, the 
Middle East, and Southeast Asia; larva migrans in Southeast 
Asia, the Caribbean, South America, and Central America; 
leishmaniasis in Central America and South America; and 
myasis in Central America. Finally, respiratory syndromes 
were more frequently reported in travelers returning from 
eastern Europe and northeastern Asia; genitourinary and 
sexually transmitted diseases (STDs) were more frequent 
in travelers from eastern Europe, Southeast Asia, and the 
Caribbean; schistosomiasis was more frequent in travellers 
from Africa and cerebromeningeal infections were more 
frequent in travelers from eastern Europe and North-Africa) 
(p<0.0001) (online Technical Appendix, available from 
www.cdc.gov/EID/content/15/11/1783-Techapp.pdf).
Also, the proportionate morbidity of some broad syn-
dromes or etiologic diagnoses was higher in persons return-
ing to speciﬁ  c European countries, as illustrated for falci-
parum malaria (Italy, France), dengue (United Kingdom), 
CHIKV infection (France), animal-related injuries requir-
ing rabies PEP (France, United Kingdom) and cerebromen-
ingeal infections (Italy) (p<0.0001). The proportionate mor-
bidity was also higher in some categories of traveler, such 
as diarrhea and dermatologic diseases (in classic tourist 
travelers), falciparum malaria and genitourinary infections 
and STDs (immigrant travelers who were VFRs), and P. 
vivax malaria (missionary/expatriate travelers) (p<0.0001). 
(For details, see online Technical Appendix.)
MCA highlights the possibility of diagnosis in certain 
groups and shows an association between German patients, 
who are classic travelers (traveling for tourism to Southeast 
and south-central Asia) and a diagnosis of acute diarrhea. 
The MCA also showed that French, Swiss, or Italian pa-
tients who are classiﬁ  ed as immigrant or expatriate travel-
ers (VFRs or travelers for missionary purposes to Africa or 
Indian Ocean islands) are most likely to seek treatment for 
febrile illness (online Technical Appendix).
Compared with the corresponding proportion of dis-
ease in non-European travelers, European classic tourist 
travelers had a lower proportionate morbidity  (adjusted 
for travel duration) for certain diagnoses, such as schis-
tosomiasis, cutaneous larva migrans, and animal-related 
injuries requiring rabies PEP, and a higher proportionate 
morbidity for genitourinary infections, STDs, and respira-
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Figure 1. Proportion (%) of different categories of returned patients 
among 17,228 patients seen in GeoSentinel sites in Europe,* 
compared with 12,663 non-European patients sampled from the 
GeoSentinel database (1997–2007). *This proportion includes 
11,848 from Germany, 2,818 from Switzerland, 971 from Italy, 931 
from France, 289 from the United Kingdom, and 371 from other 
European countries.RESEARCH
tory diseases when traveling to speciﬁ  c regions (Figure 3). 
Also, the P. falciparum malaria proportionate morbidity in 
immigrant travelers (VRFs) after travel to Africa or the In-
dian Ocean islands was higher in Europeans compared with 
non-Europeans (Figure 3).
Discussion
Despite the large number of patients investigated here 
in Europe for the assessment of travel-related illness, our 
work does not analyze all infectious illness in all returned 
patients. The results do not represent the broad spectrum of 
illness typically seen at nonspecialized primary care prac-
tice where mild or self-limited conditions would be found 
with higher frequency (19,23). The intake at sites reﬂ  ects a 
mixed population of tertiary care and self-referred patients. 
Diagnoses that may be underrepresented include diseases 
of short incubation, many cases of which manifest during 
travel. However, GeoSentinel captures a sentinel sample of 
travelers; we have no reason to believe that cases we have 
not captured would have a different pattern of geographic 
acquisition than those in GeoSentinel. Also, we cannot re-
late our data collected on ill travelers to the total number of 
travelers to or from the area concerned. Because of this ab-
sence of denominator, incidence rates cannot be calculated 
or a numerical risk provided for travel to a particular desti-
nation. Absolute risk can be estimated only by monitoring 
cohorts prospectively, as was conducted in a few studies 
in the 1980s. Relatively small sample sizes and the limited 
number of destinations visited by travelers originating in 
1 country are usually insufﬁ  cient to elucidate destination-
speciﬁ  c risk for individual diagnoses. Risk also could be 
calculated from the rate of illness in all travelers to each 
destination. However, capturing data on all ill travelers to 
just 1 destination, or even accurately ascertaining the de-
nominator of all travelers to that destination, is not easily 
accomplished. No published studies have been able to de-
scribe this approach on a multicountry or worldwide basis.
However, given these caveats, the major strengths of 
our analysis are its focus on proportionate disease and the 
large numbers of patients in the database, which reduces 
the population-speciﬁ  c bias found in many smaller stud-
ies. Important published studies on several aspects of travel 
medicine have used the GeoSentinel database, now identi-
ﬁ  ed as a main source for the epidemiology of travel-related 
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Table 2. Demographic and travel data for 17,228 European travelers seen at GeoSentinel European sites, compared with non-
European travelers, 1997–2007* 
European Non-European† 
Characteristic 
Classic 
travelers 
Immigrant 
travelers 
Expatriate 
travelers 
Classic 
travelers 
Immigrant 
travelers 
Expatriate 
travelers 
Sex            
  M  6,882 (49.5)  1,440.(59.6)  526 (58.4)  3,608 (44.5)  1,513 (50.2)  1,006 (64.9) 
  F  7,006 (50.4)  971 (40.2)  372 (41.3)  4,278 (52.8)  1,463 (48.6)  532 (34.3) 
  Unknown  25 (0.2)  4 (0.2)  2 (0.2)  215 (2.7)  37 (1.2)  11 (0.7 
Median age, y (range)  34 (0–96)  36 (0–95)  37 (1–179)  32 (0–95)  40 (2–89)  23 (1–77) 
Patient type             
  Inpatient  611 (4.4)  887 (36.7)  65 (7.2)  436 (5.4)  323 (10.7)  53 (3.4) 
  Outpatient  13,243 (95.2)  1,507 (62.4)  785 (87.2)  7,233 (89.3)  2,595 (86.1)  1,448 (93.4) 
  Unknown  59 (0.4  21 (0.9  50 (5.6)  432 (5.3)  95 (3.2)  48 (3.1) 
Median travel duration,‡ d (range)  21 (1–;212)  30 (1–180)  180 (1–1,555)  20 (1–212)  26 (1–198)  334 (1–1,010) 
Pretravel advice             
  Yes  8,212 (59.0)  525 (21.7)  518 (57.6)  4,169 (51.5)  647 (21.5)  1,209 (78.1) 
  No  3,252 (23.4)  1,206 (49.9)  186 (20.7)  2,678 (33.1)  1,927 (64.0)  216 (13.9) 
  Unknown  2,449 (17.6)  684 (28.3)  196 (21.8  1,254 (15.5  439 (14.6)  124 (8.0) 
Reason for travel             
  Tourism  11,200 (80.5)  525 (21.7)  124 (13.8)  5,317 (65.6)  813 (27.0)  81 (5.2) 
  Business  1,733 (12.5)  142 (5.9)  344 (38.2)  1,084 (13.4)  216 (7.2)  273 (17.6) 
  Missionary or volunteer work  775 (5.6)  59 (2.4)  422 (46.9)  1,225 (15.1)  137 (4.5)  1,190 (76.8) 
  Student  82 (0.6)  23 (1.0)  2 (0.2)  355 (4.4)  92 (3.1)  – 
  Healthcare seeking  8 (0.1)  –  –  –  1 (0.1)  – 
  Visiting friends or relatives  100 (0.7)  1,662 (68.8)  8 (0.9)  96 (1.2)  1,752 (58.1)  5 (0.3) 
  Military  15 (0.1)  4 (0.2)  124 (13.8)  24 (0.3)  2 (0.1)  – 
Median time between travel end and 
presentation, d (range) 
13 (1–156)  13 (1–139)  10 (1–153)  17 (1–154)  26 (1–157)  23 (1–165) 
*All values are no. (%) except as indicated. For each demographic and travel variable, univariate global analyses were used for comparing means 
(analysis of variance) or percentages (Ȥ
2 test). For example, age means (for each category) have been compared using an analysis of variance; 
percentages of men (for each category) have been compared by Ȥ
2 test. All tests have shown significant results (p<0.0001). 
†Data for 12,663 non-European patients sampled from the GeoSentinel database. 
‡Travel duration and interval time were estimated using accurate data, available for 15,969 (92.7%) Europeans and 9,828 (77.6%) non-Europeans 
exhibiting a travel-associated disease along with a recent trip (<6 mo ago). Travel-related Infectious Diseases in Europe
illness (18,19,24–27). We selected and discussed speciﬁ  c 
syndromes and their causes. The European aspect of our 
study is unique.
Most patients in our survey were outpatients. Ubiqui-
tous or cosmopolitan infections involving the skin and the 
respiratory, gastrointestinal, and urinary tracts were found 
frequently in our study as were imported tropical diseases 
(although the speciﬁ  c tropical/cosmopolitan disease ratio 
cannot be calculated accurately because etiolgoc agents were 
not systematically  identiﬁ  ed or recorded). As previously 
emphasized, healthcare providers should not overlook such 
cosmopolitan infections when examining patients returning 
from the tropics (28). Overall, of 10 ill European returned 
travelers, 4 had a gastrointestinal disorder, 2 experienced a 
febrile systemic illness, 2 sought treatment for a dermato-
logic problem, and 1 had a respiratory disease. Acute diar-
rhea is the most common travel-associated disease (10), and 
we show here that some destinations are more frequently 
associated with some speciﬁ  c causes. Also, all categories of 
European travelers to North Africa, south-central Asia, and 
the Middle East (but particularly classic tourist travelers) 
should be targeted for pretravel advice regarding diarrhea 
risk and self-treatment (29). Furthermore, the importance 
of respiratory diseases in travelers has been exempliﬁ  ed 
with clusters of measles after importation (30), and more 
recently, the emergence and global spread of inﬂ  uenza A 
pandemic (H1N1) 2009 virus (9). Moreover, seasonal in-
ﬂ  uenza, which affects 5%–15% of the world’s population 
annually and has been considered the second most frequent 
vaccine-preventable infection in travelers, is probably un-
derestimated in returned travelers (31).
We highlight here that malaria remains the most com-
mon speciﬁ  c diagnosis in ill returned patients who have a 
systemic febrile illness (23). P. falciparum was the most 
commonly identiﬁ  ed malaria species causing these infec-
tions, which mirrors situation in sub-Saharan Africa, a 
major source of malaria for European ill returned patients 
(32). The risk to travelers of acquiring malaria varies by 
destination. However, as shown here, the traveler proﬁ  le 
also is an important determinant of malaria risk. P. fal-
ciparum malaria is a rare diagnosis among native Ger-
mans traveling for tourism but it is a frequent diagnosis 
among immigrant travelers from Italy and France who 
visit friends and relatives in sub-Saharan Africa and the 
Indian Ocean islands. As shown here, immigrant travelers 
(VFRs) rarely seek pretravel advice, and they are known 
to comply poorly with malaria chemoprophylaxis (32). 
Therefore, immigrant travelers represent a major group 
at risk for imported malaria in Europe, and an improved 
approach to educate this population about risks and pro-
phylaxis needs to be developed.
Dengue is now considered one of the major causes of 
fever in ill returned travelers, who even may serve as im-
portant sentinels of new outbreaks of dengue in dengue-en-
demic areas (33). Here, dengue virus was the second most 
commonly identiﬁ  ed pathogen responsible for fever, par-
ticularly in patients who returned from Southeast Asia. The 
incidence of dengue has been considered to be higher than 
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Figure 2. Regions visited by the 17,228 European travelers 
according to their countries of residence or citizenship. The right 
column presents these categories within the comparator groups 
of 12,663 non-European patients sampled from the GeoSentinel 
database (1997–2007). 
Figure 3. Odds ratios (ORs), European (n = 13,488) versus non-
European (n = 6,900), by diagnosis and type of ill traveler, adjusted 
for travel duration. Each plot represents the estimated OR, and 
95% conﬁ  dence intervals are presented by lines. Only signiﬁ  cant 
ORs based on the comparison of groups of >75 ill patients given a 
diagnosis are shown. The 3 main exposure regions are presented 
(Africa and Indian Ocean islands (red dots and square), South 
and Central America and Caribbean (black dots), Southeast and 
south-central Asia (blue dots). *All dermatologic diagnoses also 
include leishmaniasis, animal-related injuries requiring rabies 
post-exposure prophylaxis (PEP), and larva migrans. GU-STD, 
genitourinary and sexually transmitted diseases. Dots, classic 
tourist travelers; square, immigrant travelers visiting friends and 
relatives (VFRs).RESEARCH
that of other so-called typical travel-related diseases, such 
as vaccine-preventable hepatitis A and typhoid fever (34). 
Because of rapid, intercontinental transportation, European 
physicians now encounter patients with arbovirus infec-
tions that have short incubation periods, such as dengue, 
and patients who are still viremic. These factors raise the 
possibility of introducing the virus to non–dengue-endemic 
areas where competent vectors are prevalent, as was dem-
onstrated for CHIKV in 2007 (7).
Some aspects described here may also inﬂ  uence medi-
cal practice that affects returned patients. For example, 
enteric fever caused by Salmonella infection was mainly 
observed in patients returning from south-central Asia, 
where multidrug resistance has been established and ﬂ  uo-
roquinolone resistance is increasing (35).
Our results show the increasing importance of rick-
ettsioses in ill returned travelers, particularly African tick-
bite fever, which affects travelers to sub-Saharan Africa, 
especially those who go on safari and military personnel. 
These groups of travelers need to be singled out to receive 
advice on tick-bite prevention (36).
Our study also reinforces the view that dermatologic 
conditions are a leading cause of health problems in trav-
elers (37). Pretravel advice should support the traveler’s 
use of impregnated bed nets and repellents, promote the 
practice of efﬁ  cient clothes drying and ironing to prevent 
myasis, and discourage direct contact of skin with wet soil 
to prevent larva migrans transmission.
Notably, a larger numbers of patients seeking rabies 
PEP were observed in France and the United Kingdom, 
where GeoSentinel clinics include rabies treatment centers. 
This highlights the potential for rabid animal–related inju-
ry in travelers, particularly in North Africa and the Middle 
East (24).
German ill travelers were overrepresented in our col-
lective database because of the historical development of 
GeoSentinel and the predominance of Germans among Eu-
ropean travelers. Furthermore, each GeoSentinel site has 
speciﬁ  c characteristics, and some would be considered as 
sentinel sites for diseases in speciﬁ  c categories of travel-
ers returning from particular countries. For example, at 
the site in Marseille, France, the French colonial past has 
a large effect on the proﬁ  le of imported disease. The city 
has the largest community of inhabitants from the Comoros 
Islands, Indian Ocean, including ﬁ  rst- to third-generation 
migrants. Immigrant travelers (VFRs) from the Comoros 
Islands are major importers of P. falciparum malaria and 
were key to creating the initial alert about the CHIKV dis-
ease outbreak (38).
Differences in disease patterns between countries of 
origin may reﬂ  ects national differences in the characteris-
tics of the traveling population, the distribution of travel 
destinations, and referral and access to medical care. In 
addition, accommodation standards, eating habits, and 
other risk behavior at a given destination may reﬂ  ect the 
national and cultural background of the traveler. These 
circumstances also apply when comparing European and 
non-European returned patients. However, although the 
non-European comparative group is heterogeneous, the 
diversity allows us to highlight some characteristics of 
European travel-related illnesses, such as the falciparum 
malaria within immigrant travelers (VFRs) in sub-Saharan 
Africa and the Indian Ocean islands. The economic situ-
ation of immigrants in Europe is unlikely to be as secure 
as that of second- or third-generation immigrants living 
in the United States, even if they have an easy access to 
the health system, including university hospitals in many 
cities. These factors, together with a higher likelihood of 
having severe imported diseases, such as malaria, may 
explain the high rate of immigrant travelers (VFRs) who 
were hospitalized. In Marseille, most of the immigrant 
travelers originating from Comoros claimed that some 
types of antimalarial chemoprophylaxis are too expen-
sive for a whole family who travels every 2 years to visit 
friends and family.
European and non-Europeans ill returned travelers 
may also have a different code of conduct and behavior. 
For example, classic tourist travelers from Europe to Asia 
have a higher proportion of STDs than do other travelers. 
Again, our ill travelers probably do not reﬂ  ect the whole 
population of travelers returning from the tropics with 
STDs because many probably consult their general practi-
tioners ﬁ  rst. However, a broad spectrum of STDs recently 
have been highlighted as common causes of health impair-
ment among European travelers returning from the tropics, 
and Asia has destinations known for sex tourism (39).
Furthermore, depending on the destination, tourist 
travelers seem to be less frequently afﬂ  icted by diseases 
transmitted by contact of skin with fresh water or wet soil 
(schistosomiasis and larva migrans) and interaction with 
animals (animal-related injuries  requiring rabies PEP); 
these facts suggest that they may be more compliant with 
travel health recommendations. We have no clear expla-
nation, however, for the higher respiratory disease–relat-
ed illnesses for European tourists traveling to Africa and 
America, but we note that SARS was imported to Europe 
in this way.
Conclusions
Clinicians encountering returned patients have an es-
sential role in recognizing, and communicating travel-asso-
ciated public health risks (19,23). In this context, surveil-
lance in European travelers that encompasses a wide range 
of sites in Europe, including some with local speciﬁ  city, is 
crucial to determine the epidemiology of travel-associated 
disease, to detect alarming events, and, if required, to or-
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ganize a rapid response (40). Our combined European data 
can be used as background evidence for the practice of 
travel medicine in Europe.
These members of the GeoSentinel Surveillance Network 
also contributed data: François Chappuis, University of Geneva, 
Geneva, Switzerland; Giampiero Carosi, University of Brescia, 
Brescia, Italy; Fabrice Simon and Jean Delmont, Hôpital Nord, 
Marseille, France; Gerd-Dieter Burchard, Bernhard-Nocht-Insti-
tute for Tropical Medicine, Hamburg, Germany; Rainer Weber 
and Robert Steffen, University of Zürich, Zürich, Switzerland; 
Mogens Jensenius, Ullevål University Hospital, Oslo, Norway; 
Effrossyni Gkrania-Klotsas, Addenbrooke’s Hospital, Cam-
bridge, UK; and Vanessa Field, InterHealth, London, UK. These 
additional members contributed data for Europeans nonresident 
in Europe: Prativa Pandey, Canadian International Water and 
Energy Consultants Clinic Travel Medicine Center, Kathmandu, 
Nepal; Susan MacDonald, Beijing United Family Hospital and 
Clinics, Beijing, People’s Republic of China; Poh Lian Lim and 
Annelies Wilder-Smith, Tan Tock Seng Hospital, Singapore; 
Graham Brown, Joseph Torresi, Royal Melbourne Hospital, Mel-
bourne, Victoria, Australia; Marc Shaw, Worldwise Travellers 
Health and Vaccination Centre, Auckland, New Zealand; Ale-
jandra Gurtman, Mount Sinai Medical Center, New York City, 
New York, USA (2002 Oct–2005 Aug only); Robert Muller, 
Travel Clinic Services, Johannesburg, South Africa (2004 May–
2005 Jun only); Phyllis E. Kozarsky and Carlos Franco-Paredes, 
Emory University, Atlanta, Georgia, USA; Jay S. Keystone and 
Kevin C. Kain, University of Toronto, Toronto, Ontario, Cana-
da; Dominique Meisch, International SOS Clinic, Ho Chi Minh 
City, Vietnam; Robert Kass, Travellers Medical and Vaccina-
tion Centres of Australia, Adelaide, South Australia, Australia 
(1997 Dec–2001 Mar only); Eli Schwartz, Chaim Sheba Medical 
Center, Tel Hashomer, Israel; Bradley A. Connor, Cornell Uni-
versity, New York, New York, USA; N. Jean Haulman, Davie 
Roesel, and Elaine C. Jong, University of Washington, Seattle, 
Washington, USA; Watcharapong Piyaphanee and Udomsak Si-
lachamroon, Mahidol University, Bangkok, Thailand; R. Bradley 
Sack and Robin McKenzie, Johns Hopkins University, Baltimore, 
Maryland, USA (1997 Dec–2007 Aug only); Cecilia Perret and 
Francisca Valdivieso, Pontiﬁ  cia Universidad Católica de Chile, 
Santiago, Chile; Sarah Borwein, Central Health Medical Practice, 
Hong Kong SAR, China; Carmelo Licitra and Antonio Crespo, 
Orlando Regional Health Center, Orlando, Florida, USA; Lin H. 
Chen and Mary E. Wilson, Harvard University, Cambridge, Mas-
sachusetts, USA; Thomas B. Nutman and Amy D. Klion, National 
Institutes of Health, Bethesda, Maryland, USA; Vernon Ansdell, 
Kaiser Permanente, Honolulu, Hawaii, USA (1997 Oct–2003 
Jan only); DeVon C. Hale and Stefanie S. Gelman, University of 
Utah, Salt Lake City, Utah, USA; and Hiroko Sagara, Yokohama 
Municipal Citizen’s Hospital, Yokohama, Japan.
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